BaseSpace
correlation
engine
correlation
engine
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Genome
Browser
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FGF21
,
T cell receptor signaling pathway
,
Allergy to pollen
,
Retina
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ERBB2
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Conjunctiva
Breast tissue
Kidney
Kidney cortex
Placenta
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Cardiomyopathy
Lung cancer
Brain cancer
Gastric cancer
Ovarian cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
trastuzumab
tolfenamic acid
picrotoxinin
Xamoterol
Tolazoline
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
DST
AKAP13
SCML2
LGALS4
HNRNPA0
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Assessment of HER-2 status in invasive breast cancer in Brazil.
Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on …
Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-n…
Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast C…
HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 E…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor
Safety Study of MGAH22 in HER2-positive Carcinomas
PRS-343 in HER2-Positive Solid Tumors
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab
The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ